Tag:
J. Craig Venter
Latest Headlines
Latest Headlines
CLC bio capitalizes on surge in DNA sequencing
CLC bio wants the world to know that business is good, but the world might be more interested in why its business has taken off. The Danish provider of bioinformatics software touts today that its software sales shot up 30% in 2012 with an equal jump in its number of employees.
Top 50 Industry Voices in Biotech Twittersphere -- 2012
After I last wrote about Twitter 's impact on biotech, a few FierceBiotech readers responded with skepticism. They weren't so sure that engaging on a microblogging site was a good use of their...
J. Craig Venter explores printable vaccines
Geneticist J. Craig Venter's vision for the future of vaccines may seem a little surreal: Making available downloadable software that allows people to print a vaccine and inject it at home.
Venter, Stanford build first computer model of complete organism
Computational biology has taken another big leap. The J. Craig Venter and Stanford University have pieced together the first software model of an entire organism, using massive amounts of data and computing power to simulate life processes of the tiny being.
Illumina fights Roche bid with 'poison-pill' maneuver
A day after Roche's ( $RHHBY ) hostile $5.7 billion bid to scoop up Illumina ( $ILMN ) hit the news, investors are wagering that the maker of DNA sequencing machines will attract a better offer.
San Diego's scientific community embraces Venter's "corporate approach"
Craig Venter is building a new $35 million home for his ambitious work on synthetic biology in San Diego, home to some of the world's most prestigious research institutes. And even his most outspoken
Venter research center will boast hip energy tech
J. Craig Venter has broken ground on his new, 45,000-square-foot biologics lab, which will be tucked away on a corner of UC San Diego's campus. With the kind of trademark fanfare that characterizes
Novartis, Venter team on faster vax development
Novartis is turning to J. Craig Venter to help blaze a development shortcut that can carve weeks out of the time it takes to ramp up production of a new flu vaccine. One of the bottlenecks that
Novartis and Venter team on faster vaccine development
Novartis is turning to J. Craig Venter to help blaze a development shortcut that can carve weeks off the time it takes to ramp up production of a new flu vaccine. One of the bottlenecks that appeared
Synthetic biology pioneers issue bioterror warning
As synthetic biology emerges from the sidelines to produce new therapies and fuels, the burgeoning business also promises to create tools that can be put to work on the behalf of a new generation of
